The Latest Cardiac and Vascular News
DUBLIN and LEIPZIG, Germany – January 22, 2019 – Medtronic plc (NYSE:MDT) today announced new data shared on the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) in patients with peripheral artery disease (PAD) in the superficial femoral (SFA) and popliteal arteries. Outcomes from the IN.PACT DCB Paclitaxel Safety Analysis, an independent, patient-level survival […]
TEL AVIV, Israel, Jan. 22, 2019 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced details of a new investigator-initiated trial entitled, “Initial Clinical Study of the New […]
CARLSBAD, Calif., Jan. 22, 2019 /PRNewswire/ — Acutus Medical will highlight the benefits of its AcQMap advanced cardiac imaging and mapping visualization system at AF Symposium January 24-26 in Boston. The AcQMap system enables physicians to have a more precise approach to strategically address atrial arrhythmias by uncovering the true electrical activation pattern of the heart in […]
NEW BRUNSWICK, N.J., Jan. 22, 2019 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) today announced sales of $20.4 billion for the fourth quarter of 2018, an increase of 1.0% as compared to the fourth quarter of 2017. Operational sales results increased 3.3% and the negative impact of currency was 2.3%. Domestic sales increased 1.5%. International […]
FRANKLIN LAKES, N.J., Jan. 21, 2019 /PRNewswire/ — The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.77 per common share, payable on March 29, 2019 to holders of record on March 8, 2019. The indicated annual dividend rate is $3.08 per share. In addition, the Board of Directors has declared […]
LEIPZIG, Germany and MARLBOROUGH, Mass., Jan. 22, 2019 /PRNewswire/ — Today, Boston Scientific (NYSE: BSX) announced positive 12-month data demonstrating that patients who were treated with the VICI VENOUS STENT® System for iliac and femoral vein obstructions exhibited a high rate of patent, or open, target lesions. Primary safety and efficacy results from the VIRTUS trial […]
CLEVELAND, Jan. 22, 2019 /PRNewswire/ — ViewRay, Inc. (Nasdaq: VRAY) announced today the five-year anniversary of patient treatments with MRIdian MRI-guided radiation therapy at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Missouri. As one of the world’s leading cancer centers, Siteman is known for pioneering the advancement and adoption of […]
FLAGSTAFF, Ariz.–(BUSINESS WIRE)–W. L. Gore & Associates, Inc. (Gore) today introduced reduced profiles for the most commonly used diameters of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System. The reduced profile allows physicians to perform TEVAR in patients with smaller vessels where access is challenging and aortic anatomy is tortuous, […]
ABBOTT PARK, Ill., Jan. 21, 2019 /PRNewswire/ — Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) approval of the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™, a new ablation catheter designed to help physicians accurately and effectively treat atrial fibrillation (AFib). The approval further expands Abbott’s portfolio of cardiac ablation tools that integrate […]
